Federal regulators issued final guidance for the next round of Medicare drug price negotiations yesterday but did not propose remedies [...] …
Category: Regulatory
Multiple 340B provider groups have applauded the federal government for threatening “strong” enforcement actions that led Johnson & Johnson (J&J) [...] …
Drug industry vendor Kalderos last week launched a new drug discount platform with 340B rebate capabilities as its prior lawsuit [...] …
Breaking News
J&J Abandons 340B Rebate Due to HRSA’s Enforcement Threats But Defends Model in Letter to Agency
Johnson & Johnson (J&J) notified the Health Resources and Services Department (HRSA) this morning that it will drop its 340B [...] …
Breaking News
188 Bipartisan House Members Urge HHS Action Against J&J’s ‘Unlawful’ 340B Rebate Proposal
A bipartisan group of 188 House lawmakers urged the federal government Friday to “use every enforcement tool” at its disposal [...] …
Breaking News
HRSA to J&J: End 340B Rebate by Monday or Lose Access to Key Government Health Insurance Markets
The federal agency overseeing the 340B program has doubled down on its threat to terminate Johnson & Johnson’s (J&J’s) access [...] …
A high-ranking federal regulator addressed the 340B patient definition and manufacturer audits during an unscripted Q&A session after a speech [...] …
Sanofi is requiring Arkansas hospitals to prove they legally own 340B-priced drugs until they are dispensed at contract pharmacies after [...] …
Federal regulators last Friday finalized a highly anticipated rule for the Medicaid Drug Rebate Program (MDRP) with new identifiers and [...] …
A major drug industry trade group and the federal government have asked a federal judge to continue to pause litigation [...] …